These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


510 related items for PubMed ID: 27911827

  • 1. Tau prions from Alzheimer's disease and chronic traumatic encephalopathy patients propagate in cultured cells.
    Woerman AL, Aoyagi A, Patel S, Kazmi SA, Lobach I, Grinberg LT, McKee AC, Seeley WW, Olson SH, Prusiner SB.
    Proc Natl Acad Sci U S A; 2016 Dec 13; 113(50):E8187-E8196. PubMed ID: 27911827
    [Abstract] [Full Text] [Related]

  • 2. Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer's disease.
    Cherry JD, Esnault CD, Baucom ZH, Tripodis Y, Huber BR, Alvarez VE, Stein TD, Dickson DW, McKee AC.
    Acta Neuropathol Commun; 2021 May 12; 9(1):86. PubMed ID: 33980303
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of a novel tau propagation mouse model endogenously expressing 3 and 4 repeat tau isoforms.
    Hosokawa M, Masuda-Suzukake M, Shitara H, Shimozawa A, Suzuki G, Kondo H, Nonaka T, Campbell W, Arai T, Hasegawa M.
    Brain; 2022 Mar 29; 145(1):349-361. PubMed ID: 34515757
    [Abstract] [Full Text] [Related]

  • 5. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
    Yoshida M.
    Neuropathology; 2006 Oct 29; 26(5):457-70. PubMed ID: 17080726
    [Abstract] [Full Text] [Related]

  • 6. [Neuropathology of tauopathy].
    Yoshida M.
    Brain Nerve; 2013 Dec 29; 65(12):1445-58. PubMed ID: 24323931
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS, Banks RA, Kim B, Changolkar L, Riddle DM, Leight SN, Irwin DJ, Trojanowski JQ, Lee VMY.
    J Neuropathol Exp Neurol; 2018 Mar 01; 77(3):216-228. PubMed ID: 29415231
    [Abstract] [Full Text] [Related]

  • 10. Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy.
    Cherry JD, Kim SH, Stein TD, Pothast MJ, Nicks R, Meng G, Huber BR, Mez J, Alosco ML, Tripodis Y, Farrell K, Alvarez VE, McKee AC, Crary JF.
    Brain Pathol; 2020 Sep 01; 30(5):913-925. PubMed ID: 32500646
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tau immunophenotypes in chronic traumatic encephalopathy recapitulate those of ageing and Alzheimer's disease.
    Arena JD, Smith DH, Lee EB, Gibbons GS, Irwin DJ, Robinson JL, Lee VM, Trojanowski JQ, Stewart W, Johnson VE.
    Brain; 2020 May 01; 143(5):1572-1587. PubMed ID: 32390044
    [Abstract] [Full Text] [Related]

  • 14. Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid.
    Saijo E, Ghetti B, Zanusso G, Oblak A, Furman JL, Diamond MI, Kraus A, Caughey B.
    Acta Neuropathol; 2017 May 01; 133(5):751-765. PubMed ID: 28293793
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
    Tanaka H, Martinez-Valbuena I, Forrest SL, Couto B, Reyes NG, Morales-Rivero A, Lee S, Li J, Karakani AM, Tang-Wai DF, Tator C, Khadadadi M, Sadia N, Tartaglia MC, Lang AE, Kovacs GG.
    Brain; 2024 Apr 04; 147(4):1399-1411. PubMed ID: 37972275
    [Abstract] [Full Text] [Related]

  • 18. Argyrophilic grain disease is a sporadic 4-repeat tauopathy.
    Togo T, Sahara N, Yen SH, Cookson N, Ishizawa T, Hutton M, de Silva R, Lees A, Dickson DW.
    J Neuropathol Exp Neurol; 2002 Jun 04; 61(6):547-56. PubMed ID: 12071638
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, Puig B, Rey MJ, Cardozo A, Viñals F, Ribalta T.
    Brain Pathol; 2001 Apr 04; 11(2):144-58. PubMed ID: 11303790
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.